in the manufacture of a medicament for the treatment of a brain tumour, wherein the cannabinoid content is in the range of between 5 and 100mg of the total cannabinoids present, and wherein the THC and CBD may be present as plant extracts, as pure compounds, or a combination of the two...
2005 containing tetrahydrocannabinol THC-CBD; WO 2004016246 (THC) and cannabidiol (CBD) as its GW-1000-02, principal cannabinoid components; Dronabinol/cannab Highly characterized botanical extract idiol; Nabiximols; of a defined chemotype of Cannabis Cannabis sativa L. sativa L. The major chemical...
CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTSThe invention relates to the use of one or more cannabinoids, particularly THC and/or CBD in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer. In ...
USE OF CANNABIDIOL IN COMBINATION WITH 5-HT2B RECE 专利名称：USE OF CANNABIDIOL IN COMBINATION WITH 5-HT2B RECEPTOR AGONISTS OR AMPHETAMINS IN THE TREATMENT OF EPILEPSY 发明人：Benjamin WHALLEY,Geoffrey GUY,Volker KNAPPERTZ,Royston GRAY,Rohini RANA 申请号：US16651751 申请日：20181001 公开号：US...
THC and/or non-psychoactive cannabidiol (CBD): SCI-110 for the treatment of Tourette syndrome, for the treatment of obstructive sleep apnea and Alzheimer’s disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and...
Combination Therapy of Curcumin and Disulfiram Synergistically Inhibits the Growth of B16-F10 Melanoma Cells by Inducing Oxidative Stress. Biomolecules 2022, 12, 1600. https://doi.org/10.3390/ biom12111600 Academic Editor: Vladimir N. Uversky Received: 27 September 2022 Accepted: 16 October 2022 ...
International Journal of Molecular Sciences Review Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors Stanislav Kalinin 1,2,3,* , Anna Malkova 1, Tatiana Sharonova 1, Vladimir Sharoyko 1,3 , Alexander Bunev 3 , Claudiu T. Supuran 4 and Mikhail Krasavin 1...
In one embodiment, it relates to a pure compound or as isolated or cannabinoid THCV use of plant extracts, the extract, selectively removing significant amounts of any naturally occurring THC. 在另一实施方案中,植物大麻素是CBD. In another embodiment, the plant cannabinoid is CBD. 展开 ...
Alternatively, the CBD and THC may be synthetically produced. A specific ratio of CBD and THC such as 10:1 to 1:10 (CBD:THC) or more preferably between 2:1 to 1:2 (CBD:THC) may be used.STEPHEN WRIGHTWAI LIUKATHERINE SCOTTANGUS DALGLEISH...
Alternatively, the CBD and THC may be synthetically produced. A specific ratio of CBD and THC such as 10:1 to 1:10 (CBD:THC) or more preferably between 2:1 to 1:2 (CBD:THC) may be used.Stephen WrightWai LiuKatherine ScottAngus Dalgleish...